COIMMUNE, INC.

CoImmune Inc. is a clinical-stage biotechnology company based in the United States that develops immuno-oncology therapeutics. Its key technologies include an allogeneic CAR-CIK cell therapy platform and autologous RNA loading dendritic cell technology, through which it is developing innovative treatments for liquid and solid tumors.